Self-managed abortion practices and post-abortion care experiences among women of reproductive age in Southwest Nigeria

Vivian T. Agunbiade-Oche`

Abstract

Self-managed abortion poses risks and challenges, and the current healthcare system fails to adequately address post-abortion issues. This study aimed to examine self-managed abortion practices, post-abortion care experiences, and the difficulties in accessing abortion drugs in Southwest Nigeria, among women in their reproductive ages. Qualitative research methods were employed. Between February and April 2023, fifteen in-depth interviews were conducted with women aged 15 to 49 years. Self-managed abortions were associated with both satisfying and disappointing outcomes. Women used various drugs such as misoprostol, mifepristone, Mifestad, Cytotec, white quinine, and a combination of 'alabukun' and lime to induce abortion. Accessing abortion drugs presented several challenges.In conclusion, self-managed abortion poses challenges related to accessing safe drugs and resorting to the use of alternative remedies to prescription-based drugs.  At least as a harm reduction strategy, it is crucial to ensure the availability of safe abortion medications to discourage women from choosing risky self-managed abortion methods as alternatives.

Full Text:

PDF

References

Rigterink ES, Saftlas AF and Atrash HK. Induced abortion, in Women and Health. Elsevier Inc. 2013; p. 235-250.

Gebremedhin M, Semahegn A, Usmael T and Tesfaye G. Unsafe abortion and associated factors among reproductive aged women in Sub-Saharan Africa: a protocol for a systematic review and meta-analysis. Systematic reviews, 2018. 7: p. 1-5.

Moseson H, Jayaweera R, Egwuatu I, Grosso B, Kristianingrum IA, Nmezi S, Zurbriggen R, Motana R, Bercu C and Carbone S, Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls. The Lancet Global Health, 2022. 10(1): p. e105-e113.

Performance Monitoring and Accountability. PMA, Abortion Survey Results: Nigeria. 2020.

Prada E, Bankole A, Onda T, Oladapo OT, Awolude OA and Adewole IF. Maternal near-miss due to unsafe abortion and associated short-term health and socio-economic consequences in Nigeria. African Journal of Reproductive Health, 2015. 19(2): p. 52-62.

Bell SO, Omoluabi E, OlaOlorun F, Shankar M and Moreau C. Inequities in the incidence and safety of abortion in Nigeria. BMJ global health, 2020. 5(1): p. e001814.

Bankole A, Remez L, Owolabi O, Philbin J and Williams P. From unsafe to safe abortion in Sub-Saharan Africa: Slow but steady progress. 2020.

World Health Organisation. WHO, Abortion care guideline.2022.

Kapp N, Blanchard K, Coast E, Ganatra B, Harries J, Footman K, Moore A, Owolabi O, Rossier C and Shellenberg K. Developing a forward-looking agenda and methodologies for research of self-use of medical abortion. Contraception, 2018. 97(2): p. 184-188.

Singh S, Remez L, Sedgh G, Kwok L and Onda T. Abortion worldwide 2017: uneven progress and unequal access. 2018.

Fuentes L, Baum S, Keefe-Oates B, White K, Hopkins K, Potter J and Grossman D. Texas women’s decisions and experiences regarding self-managed abortion. BMC Women's Health, 2020. 20(1): p. 1-12.

Aiken AR, Tello-Pérez LA, Madera M, Starling JE, Johnson DM, Broussard K, Padron E, Ze-Noah CA,

Baldwin A and Scott JG. Factors Associated With Knowledge and Experience of Self-managed Abortion Among Patients Seeking Care at 49 US Abortion Clinics. JAMA Network Open, 2023. 6(4): p. e238701-e238701.

Conti J. and Cahill EP. Self-managed abortion. Current Opinion in Obstetrics and Gynecology, 2019. 31(6): p. 435-440.

Grossman D, Baum SE, Andjelic D, Tatum C, Torres G, Fuentes L and Friedman J. A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: a cohort study. PLoS One, 2018. 13(1): p. e0189195.

Bury L, Aliaga Bruch S , Machicao Barbery X and Garcia Pimentel F. Hidden realities: What women do when they want to terminate an unwanted pregnancy in Bolivia. International Journal of Gynecology & Obstetrics, 2012. 118: p. S4-S9.

Manríquez IP, Standen CM, Carimoney AÁ and Richards A. Experience of clandestine use of medical abortion among university students in Chile: a qualitative study. Contraception, 2018. 97(2): p. 100-107.

Strong J. Men’s involvement in women’s abortion-related care: a scoping review of evidence from low-and middle-income countries. Sexual and Reproductive Health Matters, 2022. 30(1): p. 2040774.

Pereira BR. The influence of the Campaña Nacional por el Derecho al Aborto Legal, Seguro y Gratuito in the approval of the voluntary interruption of the pregnancy in Argentina. 2022.

Gerdts C, Fuentes L , Grossman D, White K, Keefe-Oates B, Baum SE, Hopkins K, Stolp CW and Potter JE. Impact of clinic closures on women obtaining abortion services after implementation of a restrictive law in Texas. American journal of public health, 2022. 112(9): p. 1297-1304.

Gomperts RJ, Jelinska K, Davies S, Gemzell‐Danielsson K and Kleiverda G. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services. BJOG: An International Journal of Obstetrics & Gynaecology, 2008. 115(9): p. 1171-1178.

Foster AM, Arnott G and Hobstetter M. Community-based distribution of misoprostol for early abortion: evaluation of a program along the Thailand–Burma border. Contraception, 2017. 96(4): p. 242-247.

Footman K, Scott R, Taleb F, Dijkerman S, Nuremowla S, Reiss K and Church K. Feasibility of assessing the safety and effectiveness of menstrual regulation medications purchased from pharmacies in Bangladesh: a prospective cohort study. Contraception, 2018. 97(2): p. 152-159.

Refbacks

  • There are currently no refbacks.